You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for ESKATA


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ESKATA

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 316989_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 18304_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 40267_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for ESKATA

Last updated: July 28, 2025

Introduction

ESKATA (topical hydrogen peroxide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the removal of common warts (verrucae) in adults and children aged 4 years and older. Its active pharmaceutical ingredient (API), stabilized hydrogen peroxide (H₂O₂), plays a central role in its efficacy. The availability and sourcing of bulk API are critical components in the manufacturing, regulatory compliance, and supply chain stability of ESKATA. This article provides an in-depth analysis of the key API sources, manufacturing considerations, and market dynamics associated with bulk hydrogen peroxide for ESKATA production.


Understanding the API: Hydrogen Peroxide

Hydrogen peroxide (H₂O₂) is a well-known oxidizing agent with widespread uses in medical, industrial, and domestic applications. For ESKATA, hydrogen peroxide must be stabilized, pharmaceutical-grade, and meet stringent purity standards. The pharmaceutical-grade H₂O₂ typically contains 40-60% active content, stabilized with compounds such as sodium stannate, sodium pyrophosphate, or other stabilizers to prevent decomposition during storage and use [[1]].


Key Attributes of API Sourcing for ESKATA

Regulatory Compliance

API suppliers must adhere to Good Manufacturing Practices (GMP) to meet regulatory standards set by the FDA, EMA, and other health authorities. Certificates of analysis (CoA), stability data, and purity profiles are prerequisites for validation and registration.

Purity and Quality Standards

The hydrogen peroxide API used in ESKATA must meet high purity standards (typically USP-grade or higher), with minimal contaminant levels such as heavy metals, organic impurities, and residual stabilizers.

Supply Chain Reliability

Given ESKATA's relatively niche medical application, reliable supply chains from reputable suppliers are essential to mitigate risks of shortages, especially considering the expiration of existing supply agreements or disruptions due to geopolitical or economic factors.


Primary Global API Suppliers for Hydrogen Peroxide

1. Kemira Oyj (Finland)

Kemira is a leading global supplier of hydrogen peroxide, with a focus on high-purity, pharmaceutical-grade products suitable for medical and personal care applications. Their production facilities in Finland and the US deliver stabilizers that meet pharmaceutical standards. Kemira’s hydrogen peroxide is often utilized in healthcare, cosmetics, and industrial applications [[2]].

2. Evonik Industries (Germany)

Evonik offers hydrogen peroxide solutions with high purity and stabilizer formulations. Their products are widely used in medical, cosmetic, and food industries. Evonik’s GMP-certified manufacturing lines support pharmaceutical-grade API demands, making them a key player for companies like those manufacturing ESKATA [[3]].

3. FMC Corporation (USA)

FMC produces stabilized hydrogen peroxide predominantly for industrial and healthcare markets. Their US-based operations have the capacity to supply pharmaceutical-grade hydrogen peroxide that complies with strict regulatory standards, facilitating suture, antiseptic, and wound care applications [[4]].

4. Solvay (Belgium)

Solvay’s extensive chemical portfolio includes high-quality hydrogen peroxide, supplied in pharmaceutical-grade grades suitable for topical applications. Their global footprint and GMP certifications make them a preferred API source for medical formulations [[5]].

5. Ecolab (USA)

Ecolab supplies stabilized hydrogen peroxide solutions aimed at healthcare, sanitation, and sterilization markets. Their GMP-compliant processes and rigorous quality controls enable consistent API supply for products like ESKATA [[6]].


Emerging and Niche API Manufacturers

Beyond established leaders, several smaller or emerging suppliers have gained prominence due to regional advantages, cost competitiveness, or specialized formulations.

6. Tianjin Ju Sheng Chemical Co. (China)

This Chinese manufacturer supplies stabilized hydrogen peroxide that meets international standards. While often targeted at industrial uses, some products are verified for pharmaceutical applications with proper certification [[7]]].

7. Jiamusi Xingda Chemical Co. (China)

They offer pharmaceutical-grade hydrogen peroxide, with focus on GMP compliance and long-term supply contracts, serving Asian and global markets [[8]]].

8. AkzoNobel (Netherlands)

Known for pioneering stabilizer technologies, AkzoNobel provides high-purity H₂O₂ solutions with custom stabilization formulations contributing to API stability [[9]]].


Market and Supply Chain Challenges

Regulatory Barriers and Certification

API sources must comply with evolving GMP regulations and often require extensive documentation, audits, and raw material traceability, which can lengthen procurement timelines.

Price Fluctuations

Hydrogen peroxide prices are subject to raw material costs, energy prices, and production capacity constraints. Disruptions in raw material supply, such as oxygen shortages, can create price volatility.

Environmental and Safety Regulations

Manufacturing hydrogen peroxide involves handling potentially hazardous materials; thus, suppliers must adhere to strict environmental, health, and safety protocols, impacting site capacity and operational costs.

Geopolitical Risks

China and other manufacturing hubs face geopolitical tensions, impacting export policies, trade tariffs, and supply security, directly affecting API availability for global markets.


Strategic Considerations for API Procurement

  • Supplier Qualification: Engage with multiple GMP-certified suppliers and conduct thorough audits to ensure compliance and capacity resilience.
  • Long-term Agreements: Secure contractual supply commitments to mitigate price volatility and ensure priority access.
  • Quality Assurance: Verify certificate of analysis, stability data, and batch consistency to reduce regulatory risks.
  • Regional Diversification: Balance sourcing across regions to hedge against geopolitical disruptions.

Conclusion

The sourcing of bulk API for ESKATA predominantly revolves around high-quality, GMP-compliant hydrogen peroxide suppliers. Established players such as Kemira, Evonik, FMC, Solvay, and Ecolab dominate globally, offering reliable and regulated sources vital for manufacturing this niche dermatological product. Emerging regional manufacturers expand options but require rigorous qualification processes. Navigating regulatory requirements, market dynamics, and geopolitical factors is critical for ensuring uninterrupted supply, cost stability, and product quality. As demand for ESKATA potentially grows, securing diversified, compliant API sources remains paramount for manufacturers aiming to sustain market presence and meet regulatory standards.


Key Takeaways

  • The primary API source for ESKATA is stabilized, pharmaceutical-grade hydrogen peroxide, supplied mostly by leading chemical companies with GMP certification.
  • Ensuring API purity, quality, and regulatory compliance is crucial for regulatory approval and market stability.
  • Supply risks include geopolitical tensions, raw material costs, and environmental regulations, necessitating diversified sourcing strategies.
  • Long-term supplier agreements, rigorous qualification, and quality assurance are vital to securing reliable API supply chains.
  • Regional manufacturers in China and Europe are emerging options but require comprehensive validation processes.

FAQs

1. What specifications are necessary for hydrogen peroxide API used in ESKATA?
API for ESKATA must meet USP or equivalent standards, including purity of at least 99.5%, stabilized formulations, minimal organic contaminants, and compliance with GMP regulations.

2. How does the stabilizer in hydrogen peroxide API influence its use in ESKATA?
Stabilizers prevent decomposition and density changes of hydrogen peroxide, ensuring consistent efficacy and shelf-life in topical formulations like ESKATA.

3. Are there regional differences in API quality for hydrogen peroxide?
Yes. While European and North American suppliers generally adhere to strict GMP standards, regional variations exist, necessitating validation and certification for pharmaceutical applications.

4. What are common challenges in sourcing API for niche pharmaceutical products like ESKATA?
Challenges include regulatory compliance, supply chain disruptions, price volatility, and maintaining high purity standards.

5. How can manufacturers mitigate supply risks when sourcing hydrogen peroxide API?
By diversifying suppliers, securing long-term contracts, maintaining multiple sourcing regions, and conducting rigorous supplier audits.


References

[1] United States Pharmacopeia (USP). Hydrogen Peroxide Monograph. 2023.
[2] Kemira Oyj. Product Information: Pharmaceutical Hydrogen Peroxide. 2022.
[3] Evonik Industries. Hydrogen Peroxide Applications & Specifications. 2022.
[4] FMC Corporation. Media Release: Stabilized Hydrogen Peroxide Solutions. 2021.
[5] Solvay. Industry Solutions: Pharmaceutical Hydrogen Peroxide. 2022.
[6] Ecolab. Healthcare Disinfection Solutions. 2022.
[7] Tianjin Ju Sheng Chemical Co. Company Profile & Product Specification. 2022.
[8] Jiamusi Xingda Chemical Co. GMP Certification & Product Data Sheet. 2022.
[9] AkzoNobel. Specialty Chemicals: Stabilized Peroxides. 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.